Matthias Fröhlich
13PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Mar 04, 2026
Calprotectin and serum amyloid A for disease activity assessment in giant cell arteritis and polymyalgia rheumatica: results from a prospective single-centre cohort study.Marc Schmalzing, Matthias Froehlich, Patrick P Strunz
|Jul 09, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors.Sebastian Hüper, Florian Eisele, Johannes Duell
|Apr 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht
|Jan 13, 2025
Isolated inflammatory involvement of the occipital artery in giant cell arteritis and polymyalgia rheumatica: findings from a retrospective analysis and the critical role of MRI in diagnosis.Konstanze V Guggenberger, Lukas Riedling, Daria Kern
|Dec 11, 2024
Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up study.Michael Gernert, Tobias Müller, Lukas Schweiker
Pageof 3
Frequent Collaborators
10 joint publications
Patrick-Pascal Strunz
10 joint publications
Marc Schmalzing
10 joint publications
Michael Gernert
4 joint publications
Eva Christina Schwaneck
4 joint publications
Hannah Labinsky
3 joint publications
Torsten Witte
3 joint publications
Konstanze V Guggenberger
2 joint publications
Linus Maximilian Risser
2 joint publications
Peter Bartz-Bazzanella
2 joint publications
Matthias Englbrecht